Related Experiment Video
Updated: May 30, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Transcriptional Regulation of CRD-BP by c-myc: Implications for c-myc Functions
Felicite K Noubissi1, Mikhail A Nikiforov, Nancy Colburn
1Department of Dermatology and Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Insights
The coding region determinant binding protein (CRD-BP) is reactivated in cancer. This study identifies c-myc as a novel regulator that induces CRD-BP transcription, impacting cell growth and proliferation.
Area of Science:
- Molecular Biology
- Cancer Biology
- RNA Regulation
Background:
- The coding region determinant binding protein (CRD-BP) is a multifunctional RNA-binding protein crucial for embryonic development.
- CRD-BP expression is typically low in adult tissues but reactivated and overexpressed in various cancers, correlating with aggressive disease.
- CRD-BP regulates key genes, including oncogenes like c-myc, and its dysregulation contributes to cancer progression.
Purpose of the Study:
- To elucidate the molecular mechanisms regulating CRD-BP expression.
- To identify novel transcriptional regulators of CRD-BP.
- To understand how c-myc influences CRD-BP expression and its downstream effects.
Main Methods:
- Promoter binding assays to assess c-myc interaction with the CRD-BP promoter.
- Transcriptional assays to measure c-myc-induced CRD-BP transcription.
- Analysis of downstream targets and pathways affected by c-myc-mediated CRD-BP upregulation.
Main Results:
- c-myc directly binds to the CRD-BP promoter region.
- c-myc induces the transcription of CRD-BP.
- Upregulation of CRD-BP by c-myc contributes to increased cell size, accelerated cell cycle progression, and enhanced translation regulation via modulation of β-TrCP1 and PDCD4.
Conclusions:
- c-myc is identified as a novel transcriptional regulator of CRD-BP.
- The c-myc/CRD-BP axis plays a significant role in promoting cancer-associated phenotypes.
- Targeting this regulatory pathway could offer new therapeutic strategies for cancers with CRD-BP overexpression.
Abstract:
The coding region determinant binding protein, CRD-BP, is a multifunctional RNA binding protein involved in different processes such as mRNA turnover, translation control, and localization. It is mostly expressed in fetal and neonatal tissues, where it regulates many transcripts essential for normal embryonic development. CRD-BP is scarce or absent in normal adult tissues but reactivated and/or overexpressed in various neoplastic and preneoplastic tumors and in most cell lines. Its expression has been associated with the most aggressive form of some cancers. CRD-BP is an important regulator of different genes including a variety of oncogenes or proto-oncogenes (c-myc, β-TrCP1, GLI1, etc.). Regulation of CRD-BP expression is critical for proper control of its targets as its overexpression may play an important role in abnormal cell proliferation, suppression of apoptosis, invasion, and metastasis. Molecular bases of the regulatory mechanisms governing CRD-BP expression are still not completely elucidated. In this article, we have identified c-myc as a novel transcriptional regulator of CRD-BP. We show that c-myc binds to CRD-BP promoter and induces its transcription. This induction of CRD-BP expression contributes to the role of c-myc in the regulation of translation, increase in cell size, and acceleration of cell cycle progression via a mechanism involving upregulation of β-TrCP1 levels and activities and accelerated degradation of PDCD4.
Related Concept Videos
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic cells are...
Regulation of Expression at Multiple Steps
Cis-regulatory Sequences
Cis-regulatory Sequences
Co-activators and Co-repressors

